Literature DB >> 10886400

Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor.

G Dent1, N M Munoz, X Zhu, E Rühlmann, H Magnussen, A R Leff, K F Rabe.   

Abstract

Activation of human eosinophils by platelet-activating factor (PAF) involves multiple signal transduction pathways. Among these, protein kinase C has been demonstrated both to mediate respiratory burst and to suppress an alternative pathway of activation of respiratory burst and arachidonic acid metabolism in eosinophils. We utilized inhibitors of protein tyrosine kinases (PTK) to elucidate the role of PTK in PAF-induced activation of eosinophils. Eosinophils were isolated from peripheral blood of atopic donors and stimulated with PAF in the absence or presence of broad-spectrum PTK inhibitors-genistein or lavendustin A; an inhibitor of mitogen-activated protein (MAP) kinase activation-tyrphostin AG126; or an inhibitor of Janus kinase 2 (Jak2)-tyrphostin B42 (AG490). PAF induced superoxide anion (O2-*) generation, leukotriene C4 (LTC4) release, intracellular calcium ion mobilization and tyrosine phosphorylation of multiple eosinophil proteins in a concentration-dependent manner. All of these responses were concentration-dependently inhibited by genistein; lavendustin A also exhibited potent inhibition of PAF-induced LTC4 release. AG126 had no effect on either O2-* generation or LTC4 release, while AG490 inhibited both responses, albeit less effectively than genistein. We conclude that PAF activates PTK in human eosinophils and that this signalling pathway is involved in eliciting respiratory burst and leukotriene production. The specific PTK(s) involved are unknown but may include Jak2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886400      PMCID: PMC2327005          DOI: 10.1046/j.1365-2567.2000.00037.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Role of the mitogen-activated protein kinases and tyrosine kinases during leukotriene B4-induced eosinophil activation.

Authors:  M A Lindsay; E B Haddad; J Rousell; M M Teixeira; P G Hellewell; P J Barnes; M A Giembycz
Journal:  J Leukoc Biol       Date:  1998-10       Impact factor: 4.962

2.  Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

3.  The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.

Authors:  M Ohmichi; L Pang; V Ribon; A Gazit; A Levitzki; A R Saltiel
Journal:  Biochemistry       Date:  1993-05-04       Impact factor: 3.162

4.  Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.

Authors:  A Novogrodsky; A Vanichkin; M Patya; A Gazit; N Osherov; A Levitzki
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

5.  Role of leukotrienes in airway hyperresponsiveness in guinea-pigs.

Authors:  K Ishida; R J Thomson; R R Schellenberg
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils.

Authors:  E M Zoratti; J B Sedgwick; R R Vrtis; W W Busse
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

7.  Contraction of human bronchial smooth muscle caused by activated human eosinophils.

Authors:  K F Rabe; N M Muñoz; A J Vita; B E Morton; H Magnussen; A R Leff
Journal:  Am J Physiol       Date:  1994-09

8.  Products of neutrophils and eosinophils increase the responsiveness of human isolated bronchial tissue.

Authors:  A R Hallahan; C L Armour; J L Black
Journal:  Eur Respir J       Date:  1990-05       Impact factor: 16.671

9.  Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha.

Authors:  T van der Bruggen; E Caldenhoven; D Kanters; P Coffer; J A Raaijmakers; J W Lammers; L Koenderman
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

10.  Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry.

Authors:  S Galens; N M Muñoz; K F Rabe; A Herrnreiter; D Mayer; B Morton; K McAllister; A R Leff
Journal:  Am J Physiol       Date:  1995-03
View more
  5 in total

1.  Tyrosine kinase inhibitor AG126 reduces 7-ketocholesterol-induced cell death by suppressing mitochondria-mediated apoptotic process.

Authors:  Yun Jeong Kim; Chung Soo Lee
Journal:  Neurochem Res       Date:  2009-12-03       Impact factor: 3.996

2.  A new method to evaluate anti-allergic effect of food component by measuring leukotriene B4 from a mouse mast cell line.

Authors:  Mikako Takasugi; Emi Muta; Koji Yamada; Hirofumi Arai
Journal:  Cytotechnology       Date:  2017-08-29       Impact factor: 2.058

3.  A mechanism of benefit of soy genistein in asthma: inhibition of eosinophil p38-dependent leukotriene synthesis.

Authors:  R Kalhan; L J Smith; M C Nlend; A Nair; J L Hixon; P H S Sporn
Journal:  Clin Exp Allergy       Date:  2007-11-02       Impact factor: 5.018

4.  Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.

Authors:  Dawn Eggert; Prasanta K Dash; Nawal Serradji; Chang-Zhi Dong; Pascal Clayette; Francoise Heymans; Huanyu Dou; Santhi Gorantla; Harris A Gelbard; Larisa Poluektova; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

5.  Eosinophil recruitment and activation: the role of lipid mediators.

Authors:  Tatiana Luna-Gomes; Patrícia T Bozza; Christianne Bandeira-Melo
Journal:  Front Pharmacol       Date:  2013-03-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.